HomeClinical ToolsCKD KDIGO

🫘 CKD Staging & Referral (KDIGO)

KDIGO heat-map risk stratification (eGFR stage × albuminuria stage), follow-up frequency and nephrology referral advice for CKD. Instant, browser-side.

Clinical takeaway

Refer to nephrology for eGFR < 30, A3 albuminuria or very-high risk.

Loading calculator…
Share on XLinkedInWhatsAppEmail

Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.

When to use

Stage CKD and decide on follow-up intensity and referral; the diagnosis requires abnormalities to persist ≥ 3 months.

How it works

eGFR stages G1–G5 × albuminuria A1 (< 30), A2 (30–300), A3 (> 300 mg/g) → low/moderate/high/very-high risk per the KDIGO grid.

Key points

  • Refer to nephrology for eGFR < 30, A3 albuminuria or very-high risk.
  • Also refer for rapidly falling eGFR, resistant hypertension or unexplained anaemia.
  • CKD requires abnormalities to persist ≥ 3 months.
  • G1–G2 with A1 needs another marker of kidney damage to diagnose CKD.

References

Decision support for licensed clinicians only; not a substitute for clinical judgement, diagnosis or local protocols.

Worked calculation

The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.

eGFR45 mL/min/1.73m²
Urine albumin/creatinine ratio (ACR)250 mg/g

CKD risk stratumHigh risk

  • StageG3a A2
  • eGFR stageG3a (45–59)
  • Albuminuria stageA2 (30–300 mg/g)

Frequently asked questions

What is CKD Staging & Referral (KDIGO)?
KDIGO heat-map risk stratification (eGFR stage × albuminuria stage), follow-up frequency and nephrology referral advice for CKD. Instant, browser-side.
How is CKD Staging & Referral (KDIGO) calculated? What is the core formula?
eGFR stages G1–G5 × albuminuria A1 (< 30), A2 (30–300), A3 (> 300 mg/g) → low/moderate/high/very-high risk per the KDIGO grid.
When is CKD Staging & Referral (KDIGO) used?
Stage CKD and decide on follow-up intensity and referral; the diagnosis requires abnormalities to persist ≥ 3 months.
What are the key clinical points for CKD Staging & Referral (KDIGO)?
Refer to nephrology for eGFR < 30, A3 albuminuria or very-high risk. Also refer for rapidly falling eGFR, resistant hypertension or unexplained anaemia. CKD requires abnormalities to persist ≥ 3 months. G1–G2 with A1 needs another marker of kidney damage to diagnose CKD.
What are the limits and cautions when using CKD Staging & Referral (KDIGO)?
For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
How is CKD Staging & Referral (KDIGO) calculated in practice? Can you show a worked example?
Inputs: eGFR 45 mL/min/1.73m², Urine albumin/creatinine ratio (ACR) 250 mg/g → Result: CKD risk stratum High risk(Stage: G3a A2, eGFR stage: G3a (45–59), Albuminuria stage: A2 (30–300 mg/g))

Other tools

🧪 Anion Gap🫘 CrCl🫘 eGFR🫘 FENa

中文版 →